Stellant Banner

Research1 has shown there are clinical benefits to injecting contrast and saline at different ratios to visualize the whole heart. 

  • Provide more uniform attenuation of the right and left ventricles
  • Minimize artifacts by achieving proper attenuation levels
  • Visualize the right coronary arteries and right ventricles in a single study by achieving more uniform attenuation

This informatics-ready injection system includes patented DualFlow technology and integrated saline flush. DualFlow can provide the ability to perform simultaneous injection of contrast and saline with the MEDRAD® Stellant D Injection System as seen in the video below.

 

Benefits of Dual Syringe

DualFlow can provide the ability to perform simultaneous injection of contrast and saline with the MEDRAD® Stellant D Injection System.

References: 1. Kerl JM, Ravenel JG, Nguyen SA, et al. Right heart: split-bolus injection of diluted contrast medium for visualization at coronary CT angiography. Radiology. 2008;247:356-364. 2. Jensen CT. Dual Flow Contrast Injection for Coronary CTA Improves Visualization of the Right Heart. NASCI Abstract # 05-A-69-NASCI.

The injection solution is easy to learn, set up, and use. Ease-of-use design includes:

  • Integrated saline test injection with real-time pressure monitoring
  • Snap-on/twist-off syringe design
  • Automatic plunger advance-and-retract when attaching and detaching syringes
  • Automatic filling and priming
  • Multiphase programming (and patented Hold/Pause feature)
  • Programmable pressure limit

The MEDRAD® Stellant CT injection system is backed by VirtualCare™ Remote Support and flexible support services. 

 

Scalable Options

As a scalable platform, you can add on flexible options to meet your changing CT imaging needs at any time, such as:

  • Personalizing contrast protocols at the point of care with Certegra® P3T 2.0 software
  • Contrast Dose Management and Radiation Dose Management 
  • Scanner interfacing with Certegra® Imaging System Interfaces (ISI)

5.2.3 Chart 1

 

​5.2.3 Chart 2

5.2.3 Chart 3